Boardroom Alpha
Boardroom Alpha
TRMK · Current Report (Form 8-K) · Filed November 20, 2025

Trustmark Corp — Current Report (Form 8-K)

Form
8-K
Filed
November 20, 2025
Period
Nov 17, 2025
Ticker
TRMK
Accession
0001193125-25-288633
Boardroom Alpha · Filing insights

Trustmark to issue $175M of 6% fixed-to-floating subordinated notes due 2035 to refinance $125M of 2030 notes.

About Trustmark Corp
Market cap
$2.6B
1Y TSR
+29.3%
3Y TSR
+29.2%
Board grade
C
Sector
Financial Services
CEO
Duane A Dewey
Last annual meeting: Apr 28, 2026 · View full Trustmark Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

November 17, 2025

Date of Report (Date of earliest event reported)

 

 

 

LOGO

TRUSTMARK CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Mississippi   000-03683   64-0471500

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

248 East Capitol Street, Jackson, Mississippi   39201
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (601) 208-5111

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered Pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, no par value   TRMK   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01.

Entry Into a Material Definitive Agreement.

On November 17, 2025, Trustmark Corporation (the “Company”) agreed to issue and sell (the “Offering”) $175,000,000 aggregate principal amount of its 6.00% Fixed-to-Floating Rate Subordinated Notes due 2035 (the “Notes”), pursuant to an Underwriting Agreement, dated as of November 17, 2025 (the “Underwriting Agreement”), with Keefe, Bruyette & Woods and Goldman Sachs & Co. LLC as underwriters. The Offering will be completed pursuant to the prospectus filed with the Securities and Exchange Commission as part of the Company’s Registration Statement on Form S-3 (File Number: 333-291572), as supplemented by a preliminary prospectus supplement, a final prospectus supplement and free writing prospectuses, each dated November 17, 2025. The Notes will be sold at an underwriting discount of 1.1%, resulting in net proceeds to the Company of approximately $173.1 million before deducting offering expenses. The Company intends to use the net proceeds from the Offering, after the payment of offering expenses, to repay $125,000,000 aggregate principal amount of its outstanding 3.625% Fixed-to-Floating Rate Subordinated Notes due 2030 plus accrued interest, and for general corporate purposes. The Offering is expected to close on November 20, 2025, subject to satisfaction of customary closing conditions.

The Notes will be issued under the Subordinated Indenture, dated as of November 25, 2020 (the “Subordinated Indenture”), between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”), as supplemented by the Second Supplemental Indenture, to be dated as of November 20, 2025 (the “Second Supplemental Indenture,” and, together with the Subordinated Indenture, the “Indenture”).

From and including the date of issuance to, but excluding, December 1, 2030 or the date of earlier redemption, the Notes will bear interest at a fixed rate of 6.00% per year, payable semi-annually in arrears on June 1 and December 1 of each year, commencing on June 1, 2026. Thereafter, from and including December 1, 2030, to, but excluding, the maturity date, December 1, 2035, or the date of earlier redemption, the Notes will bear interest at a floating rate per year equal to the Benchmark rate, which is expected to be Three-Month Term SOFR (each as defined in the Indenture), plus 260 basis points, payable quarterly in arrears on March 1, June 1, September 1 and December 1 of each year, commencing on March 1, 2031. Notwithstanding the foregoing, if the Benchmark rate is less than zero, then the Benchmark rate shall be deemed to be zero.

The Notes, when issued, will be the Company’s unsecured, subordinated obligations and will (i) rank junior in right of payment and upon liquidation to any of the Company’s existing and future Senior Indebtedness (as defined in the Indenture), whether secured or unsecured; (ii) rank equal in right of payment and upon liquidation with any of the Company’s existing and future subordinated indebtedness the terms of which provide that such indebtedness ranks equally with promissory notes, bonds, debentures and other evidences of indebtedness of types that include the Notes; (iii) rank senior in right of payment and upon liquidation with the Company’s existing junior subordinated debentures underlying outstanding trust preferred securities and any indebtedness the terms of which provide that such indebtedness ranks junior to promissory notes, bonds, debentures and other types of indebtedness that include the Notes; and (iv) be effectively subordinated to all of the existing and future indebtedness, deposits and other liabilities of Trustmark Bank and the Company’s other current and future subsidiaries, including, without limitation, Trustmark Bank’s liabilities to depositors in connection with the deposits in Trustmark Bank, its liabilities to general creditors and its liabilities arising during the ordinary course or otherwise.

The Notes may be redeemed at the Company’s option under certain circumstances, as described in the Indenture.

The foregoing summary of the terms of the Underwriting Agreement, the Indenture and the Notes does not purport to be complete and is subject to, and qualified in its entirety by, the full text of (i) the Underwriting Agreement, (ii) the Subordinated Indenture, (iii) the form of Second Supplemental Indenture, and (iv) the form of the Notes, each of which is attached hereto as an exhibit and is incorporated herein by reference.

 

Item2.03.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 above is incorporated by reference into this Item 2.03.


Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are filed with this Current Report on Form 8-K:

 

Exhibit
Number

  

Description of Exhibits

 1.1

   Underwriting Agreement, dated as of November 17, 2025, by and between Trustmark Corporation and Keefe, Bruyette & Woods and Goldman Sachs & Co. LLC

 4.1

   Subordinated Indenture, dated as of November 25, 2020, by and between Trustmark Corporation and Wilmington Trust, National Association, as trustee (incorporated by reference to Exhibit 4.6 to Trustmark Corporation’s Registration Statement on Form S-3, filed with the U.S. Securities and Exchange Commission on November 17, 2025).

 4.2

   Form of Second Supplemental Indenture, by and between Trustmark Corporation and Wilmington Trust, National Association, as trustee.

 4.3

   Form of 6.00% Fixed-to-Floating Rate Subordinated Notes due 2035 (included in Exhibit 4.2).

 5.1

   Opinion of Covington & Burling LLP.

 5.2

   Opinion of Brunini, Grantham, Grower & Hewes, PLLC.

23.1

   Consent of Covington & Burling LLP (included in Exhibit 5.1).

23.2

   Consent of Brunini, Grantham, Grower & Hewes, PLLC (included in Exhibit 5.2).

104

   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TRUSTMARK CORPORATION

 

BY:  

/s/ Thomas C. Owens

  Thomas C. Owens
  Treasurer and Principal Financial Officer
DATE:   November 19, 2025
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Trustmark Corp (TRMK)

Reference

Frequently asked questions

When did Trustmark Corp file this 8-K?
Trustmark Corp (TRMK) filed this Current Report (Form 8-K) with the SEC on November 20, 2025. The accession number assigned by EDGAR is 0001193125-25-288633.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Trustmark to issue $175M of 6% fixed-to-floating subordinated notes due 2035 to refinance $125M of 2030 notes. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Trustmark Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Trustmark Corp has filed under CIK 36146, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer